| 
		Mental health issues in kids rose during pandemic; awareness and use of 
		COVID treatments is low
		 Send a link to a friend 
		
		 [April 29, 2022] 
		By Nancy Lapid 
 (Reuters) - The following is a summary of 
		some recent studies on COVID-19. They include research that warrants 
		further study to corroborate the findings and that has yet to be 
		certified by peer review.
 
 Pandemic linked with mental health issues in kids
 
 The COVID-19 pandemic has profoundly impacted the mental health of 
		children and adolescents, researchers say, based on their analysis of 
		findings from 17 earlier studies.
 
 The studies - published in 2020 and 2021 - found unusually high rates of 
		anxiety, depression, sleep disorders, suicidal behavior, stress-related 
		disorders, attention-deficit/hyperactivity disorder, and other mental 
		health problems during the pandemic. Individual behaviors such as 
		hobbies, praying, and listening to music were associated with positive 
		mental health, the studies also found. "Mental health problems were more 
		common in those with low socioeconomic status, lack of social 
		connections and support, adverse family relationships, restricted 
		mobility," among other factors including school closures and "COVID-related 
		health experiences within family or community," said Dr. M. Mahbub 
		Hossain of Texas A&M University, who coauthored a report posted on 
		Tuesday on medRxiv ahead of peer review.
 
		
		 
		"In many places, school and community mental health resources and 
		services became unavailable or inaccessible, making it difficult for 
		children and adolescents to receive timely mental healthcare," Hossain 
		said, adding there is a need for "multipronged efforts to alleviate the 
		immediate and future health and social consequences" of the pandemic on 
		the mental health of children and teens.
 Awareness, use of anti-COVID drugs is low
 
 Fewer than 2% of nonhospitalized high-risk patients with COVID-19 are 
		receiving drugs that can limit the extent of their illness, survey 
		results suggest.
 
 In March 2022, researchers recruited 1,159 people from 37 states who 
		were positive for SARS-CoV-2 on PCR tests and asked whether they knew 
		about or had taken effective treatments for the virus, such as 
		monoclonal antibodies or oral antiviral drugs molnupiravir from Merck & 
		Co or Pfizer's Paxlovid. Among the 241 individuals older than 65, whose 
		age puts them at risk for severe COVID-19, 66% were aware of treatments 
		and 36.3% had sought them, but only 1.7% reported use of such drugs, 
		according to a report posted on Tuesday on medRxiv ahead of peer review.
 
 [to top of second column]
 | 
            
			 
            
			Palestinian children participate in a mental health support session 
			in Khan Younis in the southern Gaza Strip, June 6, 2021. REUTERS/Ibraheem 
			Abu Mustafa 
            
			 Among patients under 65, even fewer 
			were aware of the treatments and had sought them, and rates of use 
			were barely higher than among the older group. "More awareness of 
			effective medicines for COVID-19 among the public and healthcare 
			workers is needed to prevent serious disease and death," said study 
			leader Dr. Noah Kojima of the University of California, Los Angeles.
			
 Airliner wastewater shows Omicron entering France by plane
 
 Airplane wastewater tests show that requiring proof of COVID 
			vaccination and negative tests before international flights does not 
			necessarily protect countries from the spread of new variants.
 
 Researchers found the Omicron variant in wastewater from two 
			commercial airplanes that flew from Ethiopia to France in December 
			2021 even though passengers had been required to take COVID tests 
			before boarding and show vaccination cards. "This can be explained 
			by two things," said study leader Dr Bernard La Scola of 
			Aix-Marseille University in France. First, on long journeys, tests 
			can be negative the day before departure and positive on arrival, 
			"the virus not having yet multiplied enough on the day of the test 
			to be detectable." Second, people can obtain fake documentation. 
			Some passengers told him it was very easy to buy false-negative 
			tests.
 
 It is not practical to test every passenger coming off a long-haul 
			flight, he acknowledged. One solution might be to test the plane's 
			wastewater as soon as it lands, with a result obtained before 
			passengers pass through customs and baggage claim, his team 
			suggested in a paper posted on medRxiv ahead of peer review. If the 
			wastewater is positive, passengers can be tested before they exit, 
			however, that approach would only be worthwhile in countries where a 
			new variant is not yet circulating. "As soon as the virus circulates 
			a lot in the country it is useless," La Scola said.
 
 (Reporting by Nancy Lapid; Editing by Bill Berkrot)
 
			[© 2022 Thomson Reuters. All rights 
			reserved.]  This 
			material may not be published, broadcast, rewritten or 
			redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			 |